cinthia drachenberg pancreas summary banff 2013 meeting in brazil
DESCRIPTION
Pancreas summary from 12th Banff Conference on Transplant Pathology from the meeting in Comandatuba-Bahia, Brazil on August 23rd, 2013 http://cybernephrology.ualberta.ca/banff/2013TRANSCRIPT
![Page 1: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/1.jpg)
of
PANCREAS ALLOGRAFTS SESSION: SUMMARY
![Page 2: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/2.jpg)
• Jon Odorico
Pancreatic AMR – Clinicopathological correlations and experience at Wisconsin-Madison.
![Page 3: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/3.jpg)
Study Design
• Single center, retrospective study of “for-cause” pancreas
allograft biopsies• 94 Bx from 49 patients
• 162 Pancreas Transplants 2006-09 All biopsies had C4d staining – IHC on paraffin sections• Majority (79/94) of bx had DSA data – Luminex SAB
assay
Niederhaus et al. AJT, in press
![Page 4: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/4.jpg)
Summary Acute AMR of the Pancreas Transplant
• Acute AMR Occurs in ~10% of patients in the first year
• Risk Factors: Solitary pancreas transplant, Non-primary SPK transplant, Donor/recipient race mismatch, Female recipient
• Patients having AMR did not have worse graft survival than patients having AMR/ACR or ACR, but do have worse outcomes than patients having no rejection
• DSA+C4d- rejection is uncommon but does occur, C4d+DSA- rejection occurs; DSA alone is not diagnostic Niederhaus et al. AJT in press
![Page 5: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/5.jpg)
• Surya Seshan
![Page 6: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/6.jpg)
![Page 7: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/7.jpg)
Summary and Conclusions• Routine C4d staining on all pancreas allograft
biopsies is the current practice.• C4d staining along with detectable DSA remain
the best method to diagnose AbMR in pancreas transplants.
• Typical morphologic findings may not be apparent in early or late AbMR cases.
• Further studies to examine all aspects of C4d staining and its relationship to DSA and morphological findings in the diagnosis of AbMR is needed.
• Further develop and define criteria for chronic (active) AbMR.
![Page 8: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/8.jpg)
• Hanneke de Kort
![Page 9: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/9.jpg)
Banff 2013 9
1. Biopsy data: Leiden + Maryland
de Kort et al, 2010 AJT
![Page 10: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/10.jpg)
Banff 2013 10
2. Tq data: Leiden
26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
27 3 f class II 1 0 0 1 0 0 0 0 0 0 n28 3 f class II 1 1 1 1 0 1 3 1 1 0 d29 3 f class I&II 1 - 0 2 1 1 3 2 1 0 f30 3 d class II 1 1 0 2 1 1 3 2 1 0 n/a31 3 d class I&II 1 - 0 0 0 1 3 2 0 0 n/a32 3 d class II 1 0 1 1 0 1 0 0 1 0 d33 3 d class I&II 0 - 0 0 0 1 3 2 1 0 n
26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
27 3 f class II 1 0 0 1 0 0 0 0 0 0 n28 3 f class II 1 1 1 1 0 1 3 1 1 0 d29 3 f class I&II 1 - 0 2 1 1 3 2 1 0 f30 3 d class II 1 1 0 2 1 1 3 2 1 0 n/a31 3 d class I&II 1 - 0 0 0 1 3 2 0 0 n/a32 3 d class II 1 0 1 1 0 1 0 0 1 0 d33 3 d class I&II 0 - 0 0 0 1 3 2 1 0 n
26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
27 3 f class II 1 0 0 1 0 0 0 0 0 0 n28 3 f class II 1 1 1 1 0 1 3 1 1 0 d29 3 f class I&II 1 - 0 2 1 1 3 2 1 0 f30 3 d class II 1 1 0 2 1 1 3 2 1 0 n/a31 3 d class I&II 1 - 0 0 0 1 3 2 0 0 n/a32 3 d class II 1 0 1 1 0 1 0 0 1 0 d33 3 d class I&II 0 - 0 0 0 1 3 2 1 0 n
26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
27 3 f class II 1 0 0 1 0 0 0 0 0 0 n28 3 f class II 1 1 1 1 0 1 3 1 1 0 d29 3 f class I&II 1 - 0 2 1 1 3 2 1 0 f30 3 d class II 1 1 0 2 1 1 3 2 1 0 n/a31 3 d class I&II 1 - 0 0 0 1 3 2 0 0 n/a32 3 d class II 1 0 1 1 0 1 0 0 1 0 d33 3 d class I&II 0 - 0 0 0 1 3 2 1 0 n
18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
19 2 n class II 1 1 0 0 0 1 3 1 1 0 n/a20 2 f n 0 0 0 0 0 0 0 2 0 0 n21 2 f n 0 0 0 1 0 1 0 2 0 1 n22 2 d n 1 1 1 1 1 0 2 2 0 0 n/a23 2 d n 0 0 1 0 0 0 0 2 0 0 n24 2 d n 1 0 1 0 0 1 3 0 0 0 n/a25 2 f not tested 1 1 0 0 0 0 1 0 0 1 f26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
19 2 n class II 1 1 0 0 0 1 3 1 1 0 n/a20 2 f n 0 0 0 0 0 0 0 2 0 0 n21 2 f n 0 0 0 1 0 1 0 2 0 1 n22 2 d n 1 1 1 1 1 0 2 2 0 0 n/a23 2 d n 0 0 1 0 0 0 0 2 0 0 n24 2 d n 1 0 1 0 0 1 3 0 0 0 n/a25 2 f not tested 1 1 0 0 0 0 1 0 0 1 f26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
19 2 n class II 1 1 0 0 0 1 3 1 1 0 n/a20 2 f n 0 0 0 0 0 0 0 2 0 0 n21 2 f n 0 0 0 1 0 1 0 2 0 1 n22 2 d n 1 1 1 1 1 0 2 2 0 0 n/a23 2 d n 0 0 1 0 0 0 0 2 0 0 n24 2 d n 1 0 1 0 0 1 3 0 0 0 n/a25 2 f not tested 1 1 0 0 0 0 1 0 0 1 f26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
19 2 n class II 1 1 0 0 0 1 3 1 1 0 n/a20 2 f n 0 0 0 0 0 0 0 2 0 0 n21 2 f n 0 0 0 1 0 1 0 2 0 1 n22 2 d n 1 1 1 1 1 0 2 2 0 0 n/a23 2 d n 0 0 1 0 0 0 0 2 0 0 n24 2 d n 1 0 1 0 0 1 3 0 0 0 n/a25 2 f not tested 1 1 0 0 0 0 1 0 0 1 f26 2 d not tested 1 0 0 1 0 0 0 0 0 0 n
1 1 n n 0 0 0 0 0 0 1 2 - 0 n/a2 1 n n 0 1 0 0 0 0 0 2 0 3 n3 1 n n 0 0 0 0 0 0 0 0 0 0 n4 1 n n 0 0 0 0 0 0 0 0 0 0 f5 1 n n 1 1 1 0 0 0 2 2 0 0 n6 1 n n 1 1 0 1 0 0 3 1 1 0 n7 1 n n 1 - 1 1 0 0 2 0 1 0 n8 1 n n 0 0 0 0 0 0 0 0 0 0 n/a9 1 n n 1 - 1 0 0 0 3 2 1 0 n10 1 n n 0 0 0 1 0 0 0 2 0 0 f11 1 n n 1 1 1 2 0 1 3 2 0 0 n12 1 n n 1 - 1 0 0 0 1 0 0 0 n/a13 1 n n 0 0 1 0 0 0 0 0 0 0 n14 1 n n 1 1 1 0 0 0 1 0 0 0 n/a15 1 n not tested 1 1 0 0 0 0 2 0 0 0 n/a16 1 n not tested 0 0 0 0 0 0 0 0 0 0 n17 1 n not tested 0 0 1 0 0 0 0 0 0 0 f18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
1 1 n n 0 0 0 0 0 0 1 2 - 0 n/a2 1 n n 0 1 0 0 0 0 0 2 0 3 n3 1 n n 0 0 0 0 0 0 0 0 0 0 n4 1 n n 0 0 0 0 0 0 0 0 0 0 f5 1 n n 1 1 1 0 0 0 2 2 0 0 n6 1 n n 1 1 0 1 0 0 3 1 1 0 n7 1 n n 1 - 1 1 0 0 2 0 1 0 n8 1 n n 0 0 0 0 0 0 0 0 0 0 n/a9 1 n n 1 - 1 0 0 0 3 2 1 0 n10 1 n n 0 0 0 1 0 0 0 2 0 0 f11 1 n n 1 1 1 2 0 1 3 2 0 0 n12 1 n n 1 - 1 0 0 0 1 0 0 0 n/a13 1 n n 0 0 1 0 0 0 0 0 0 0 n14 1 n n 1 1 1 0 0 0 1 0 0 0 n/a15 1 n not tested 1 1 0 0 0 0 2 0 0 0 n/a16 1 n not tested 0 0 0 0 0 0 0 0 0 0 n17 1 n not tested 0 0 1 0 0 0 0 0 0 0 f18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
1 1 n n 0 0 0 0 0 0 1 2 - 0 n/a2 1 n n 0 1 0 0 0 0 0 2 0 3 n3 1 n n 0 0 0 0 0 0 0 0 0 0 n4 1 n n 0 0 0 0 0 0 0 0 0 0 f5 1 n n 1 1 1 0 0 0 2 2 0 0 n6 1 n n 1 1 0 1 0 0 3 1 1 0 n7 1 n n 1 - 1 1 0 0 2 0 1 0 n8 1 n n 0 0 0 0 0 0 0 0 0 0 n/a9 1 n n 1 - 1 0 0 0 3 2 1 0 n10 1 n n 0 0 0 1 0 0 0 2 0 0 f11 1 n n 1 1 1 2 0 1 3 2 0 0 n12 1 n n 1 - 1 0 0 0 1 0 0 0 n/a13 1 n n 0 0 1 0 0 0 0 0 0 0 n14 1 n n 1 1 1 0 0 0 1 0 0 0 n/a15 1 n not tested 1 1 0 0 0 0 2 0 0 0 n/a16 1 n not tested 0 0 0 0 0 0 0 0 0 0 n17 1 n not tested 0 0 1 0 0 0 0 0 0 0 f18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
1 1 n n 0 0 0 0 0 0 1 2 - 0 n/a2 1 n n 0 1 0 0 0 0 0 2 0 3 n3 1 n n 0 0 0 0 0 0 0 0 0 0 n4 1 n n 0 0 0 0 0 0 0 0 0 0 f5 1 n n 1 1 1 0 0 0 2 2 0 0 n6 1 n n 1 1 0 1 0 0 3 1 1 0 n7 1 n n 1 - 1 1 0 0 2 0 1 0 n8 1 n n 0 0 0 0 0 0 0 0 0 0 n/a9 1 n n 1 - 1 0 0 0 3 2 1 0 n10 1 n n 0 0 0 1 0 0 0 2 0 0 f11 1 n n 1 1 1 2 0 1 3 2 0 0 n12 1 n n 1 - 1 0 0 0 1 0 0 0 n/a13 1 n n 0 0 1 0 0 0 0 0 0 0 n14 1 n n 1 1 1 0 0 0 1 0 0 0 n/a15 1 n not tested 1 1 0 0 0 0 2 0 0 0 n/a16 1 n not tested 0 0 0 0 0 0 0 0 0 0 n17 1 n not tested 0 0 1 0 0 0 0 0 0 0 f18 1 n not tested 0 0 0 0 0 0 0 0 0 0 n
AMR negative
Suspicious for AMR
Acute AMR
![Page 11: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/11.jpg)
Banff 2013 11
3. Data: London
• All 17 Tq; DSA and C4d negative
• 58 bx; – 8 Bx had no arteries sampled– Includes PAK and PTA
![Page 12: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/12.jpg)
Banff 2013 12
Conclusion
Consistency with kidney so far
For pancreas allografts intimal arteritis can be indicative of ACMR as well as AMR, regardless of the severity
![Page 13: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/13.jpg)
Immunophenotypical studies on pancreas tx inflammation
Erika Rangel (15 bx, CD68)
John Papadimitriou (46 bx, CD3,CD20,CD68)
![Page 14: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/14.jpg)
Discussion (Erika Rangel)
Macrophage infiltration in pancreas graft:
Occurs in both acute AMR and TCMR
Is associated with the severity of the TCMR
Has negative impact on pancreas graft survival
Does not occur in significant numbers in the later
fibrosing stages
![Page 15: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/15.jpg)
Conclusions (John Papadimitriou)
CD3 increase proportionally with grades of ACMR, AMR and stage.
CD20 increase proportionally with ACMR and AMR and stage.
CD68 increase proportionally with ACMR and AMR, but not stage.
![Page 16: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/16.jpg)
CD3 CD3
CD20 CD20
ACMR I-IIStage I-II
*
![Page 17: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/17.jpg)
Diagnosis of rejection in grafted duodenal cuff
Determine if a biopsy of the grafted duodenal cuff can be a surrogate for a pancreas biopsy
![Page 18: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/18.jpg)
Erik Larsson and team – Ongoing prospective studies
Uppsala University, Sweden
•Approximately 200 samples in 50 patients
•Have used these biopsies for clinical monitoring and guidance of therapeutic decisions
•Excellent graft outcomes
![Page 19: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/19.jpg)
Danniele Holanda – Pilot retrospective studies on archival material of 21 pancreas samples incidentally containing duodenal tissue, to evaluate the degree of concordance of pathological findings in each pair.
There was >70% full concordance in the diagnosis and grade of rejection.
The rest of the sampled were discordant but the disagreement was of no more than 1 grade (i.e. indeterminate vs grade 1)
![Page 20: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/20.jpg)
Myriam Leon Fradejas (Malaga, Spain)
Graft failure due to deposition of islet amyloid
![Page 21: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/21.jpg)
Under recognition of Islet processes
• The Banff pancreas group started working on a set of recommendations for a diagnostic algorithm of late hyperglycemia in order to aid in the identification of islet pathology: recurrent autoimmune DM and islet amyloidosis.
• Topic of extensive discussions on 2011 Banff meeting.
![Page 22: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/22.jpg)
Issues with diagnostic criteria and grading schema
• “capillaritis” • Vascular lesions• etc
• Hanneke de Kort and Candice Roufosse have made a preliminary analysis of the most important issues that need attention and this will be the basis to proceed with group discussions.
![Page 23: Cinthia Drachenberg Pancreas Summary Banff 2013 Meeting in Brazil](https://reader036.vdocuments.net/reader036/viewer/2022062418/553b51764a79593e298b468a/html5/thumbnails/23.jpg)
of
Good bye Comandatuba…